EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Myrcene Salvages Rotenone-Induced Loss of Dopaminergic Neurons by Inhibiting Oxidative Stress, Inflammation, Apoptosis, and Autophagy

Sheikh Azimullah iD, Richard L Jayaraj iD, Mohamed Fizur Nagoor Meeran iD, Fakhreya Y Jalal, Abdu Adem iD, Shreesh Ojha iD, Rami Beiram

Molecules · 2023

DOI: 10.3390/molecules28020685 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Sheikh Azimullah und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United …. Hauptthemen laut MEDLINE: Antioxidants, Parkinson Disease. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United Arab Emirates and the office of Research and Graduate Studies, College of Medicine and Health Sciences, UAE University, UAE University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease (PD) is characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta, resulting in motor deficits. The exact etiology of PD is currently unknown; however, the pathological hallmarks of PD include excessive production of reactive oxygen species, enhanced neuroinflammation, and overproduction of α-synuclein. Under normal physiological conditions, aggregated α-synuclein is degraded via the autophagy lysosomal pathway. However, impairment of the autophagy lysosomal pathway results in α-synuclein accumulation, thereby facilitating the pathogenesis of PD. Current medications only manage the symptoms, but are unable to delay, prevent, or cure the disease. Collectively, oxidative stress, inflammation, apoptosis, and autophagy play crucial roles in PD; therefore, there is an enormous interest in exploring novel bioactive agents of natural origin for their protective roles in PD. The present study evaluated the role of myrcene, a monoterpene, in preventing the loss of dopaminergic neurons in a rotenone (ROT)-induced rodent model of PD, and elucidated the underlying mechanisms. Myrcene was administered at a dose of 50 mg/kg, 30 min prior to the intraperitoneal injections of ROT (2.5 mg/kg). Administration of ROT caused a considerable loss of dopaminergic neurons, subsequent to a significant reduction in the antioxidant defense systems, increased lipid peroxidation, and activation of microglia and astrocytes, along with the production of pro-inflammatory cytokines (IL-6, TNF-α, IL-1β) and matrix metalloproteinase-9. Rotenone also resulted in impairment of the autophagy lysosomal pathway, as evidenced by increased expression of LC3, p62, and beclin-1 with decreased expression in the phosphorylation of mTOR protein. Collectively, these factors result in the loss of dopaminergic neurons. However, myrcene treatment has been observed to restore antioxidant defenses and attenuate the increase in concentrations of lipid peroxidation products, pro-inflammatory cytokines, diminished microglia, and astrocyte activation. Myrcene treatment also enhanced the phosphorylation of mTOR, reinstated neuronal homeostasis, restored autophagy-lysosomal degradation, and prevented the increased expression of α-synuclein following the rescue of dopaminergic neurons. Taken together, our study clearly revealed the mitigating effect of myrcene on dopaminergic neuronal loss, attributed to its potent antioxidant, anti-inflammatory, and anti-apoptotic properties, and favorable modulation of autophagic flux. This study suggests that myrcene may be a potential candidate for therapeutic benefits in PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntioxidantsParkinson DiseaseHumansalpha-SynucleinApoptosisAutophagyCytokinesDopaminergic NeuronsInflammationOxidative StressRotenoneAlkenesAcyclic Monoterpenes

Stichwörter der Autor:innen

Parkinson’s diseaseautophagic fluxinflammationmyrceneoxidative stressrotenone

Substanzen

alpha-SynucleinAntioxidantsCytokinesRotenonemyrceneAlkenesAcyclic Monoterpenes

Autor:innen und Institutionen

  • Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.
  • Department of Pharmacology, College of Medicine and Health Sciences, Khalifa University, Abu Dhabi P.O. Box 127788, United Arab Emirates.

ORCID-Profile: Sheikh Azimullah, Richard L Jayaraj, Mohamed Fizur Nagoor Meeran, Abdu Adem, Shreesh Ojha

Förderung

  • United Arab Emirates and the office of Research and Graduate Studies, College of Medicine and Health Sciences, UAE University
  • UAE University

Zitieren

APA

Azimullah, S., Jayaraj, R. L., Meeran, M. F. N., Jalal, F. Y., Adem, A., Ojha, S., & Beiram, R. (2023). Myrcene Salvages Rotenone-Induced Loss of Dopaminergic Neurons by Inhibiting Oxidative Stress, Inflammation, Apoptosis, and Autophagy. Molecules. https://doi.org/10.3390/molecules28020685

Vancouver

Azimullah S, Jayaraj RL, Meeran MFN, Jalal FY, Adem A, Ojha S, et al. Myrcene Salvages Rotenone-Induced Loss of Dopaminergic Neurons by Inhibiting Oxidative Stress, Inflammation, Apoptosis, and Autophagy. Molecules. 2023. doi:10.3390/molecules28020685

BibTeX
@article{Azimullah2023,
  author = {Azimullah, Sheikh and Jayaraj, Richard L and Meeran, Mohamed Fizur Nagoor and Jalal, Fakhreya Y and Adem, Abdu and Ojha, Shreesh and Beiram, Rami},
  title = {Myrcene Salvages Rotenone-Induced Loss of Dopaminergic Neurons by Inhibiting Oxidative Stress, Inflammation, Apoptosis, and Autophagy},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28020685}
}
Kostenlos starten →